![Kathryn Gallaway, MD (@ke_gallaway) 's Twitter Profile](https://pbs.twimg.com/profile_images/1691639298133770241/XaTouUs5_200x200.jpg)
Kathryn Gallaway, MD
@ke_gallaway
34 y/o G2P2 presents w/ insatiable thirst for knowledge of unknown etiology | Philosophy @RiceUniversity | MD @UTSWNews | Associate Medical Director @DAVAOnc
ID: 1558842292605259777
https://www.linkedin.com/in/kathryn-gallaway-845136236/ 14-08-2022 15:46:19
958 Tweet
383 Followers
917 Following
![Kathryn Gallaway, MD (@ke_gallaway) 's Twitter Profile Photo Kathryn Gallaway, MD (@ke_gallaway) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1691639298133770241/XaTouUs5_200x200.jpg)
Dr. Doris Hansen Moffitt Cancer Center discusses CAR-T moving to earlier LOT in MM, necessitating more refined patient selection tools MyCARe is the first model to predict outcome to CAR based on: 🦴EMD/PCL 🧬High-risk cytogenetics 🩸Ferritin 💊LEN response ncbi.nlm.nih.gov/pmc/articles/P…
![Kathryn Gallaway, MD (@ke_gallaway) on Twitter photo Dr. Doris Hansen <a href="/MoffittNews/">Moffitt Cancer Center</a> discusses CAR-T moving to earlier LOT in MM, necessitating more refined patient selection tools
MyCARe is the first model to predict outcome to CAR based on:
🦴EMD/PCL
🧬High-risk cytogenetics
🩸Ferritin
💊LEN response
ncbi.nlm.nih.gov/pmc/articles/P… Dr. Doris Hansen <a href="/MoffittNews/">Moffitt Cancer Center</a> discusses CAR-T moving to earlier LOT in MM, necessitating more refined patient selection tools
MyCARe is the first model to predict outcome to CAR based on:
🦴EMD/PCL
🧬High-risk cytogenetics
🩸Ferritin
💊LEN response
ncbi.nlm.nih.gov/pmc/articles/P…](https://pbs.twimg.com/media/GUnQhE6bEAAM8Db.jpg)